The role of PET in localization of neuroendocrine and adrenocortical tumors

Annals of the New York Academy of Sciences

Volumn 970, Issue , 2002, Pages 159-169

  Eriksson, Barbro ^a   Bergström, Mats ^a   Sundin, Anders ^a   Juhlin, Claes ^a   Örlefors, Håkan ^a   Öberg, Kjell ^a   Långström, Bengt ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

5 hydroxytryptophan (5 HTP); L dihyroxyphenylalanine (L DOPA); Metomidate; Neuroendocrine tumors; Positron emission tomography; Whole body PET

Indexed keywords

5 HYDROXYTRYPTOPHAN; CARBIDOPA; CARBON 11; CORTICOTROPIN; DECARBOXYLASE INHIBITOR; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER; LEVODOPA; OCTREOTIDE; SEROTONIN;

ADRENAL CORTEX TUMOR; CARCINOID; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; HUMAN; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; SCINTIGRAPHY; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; URINARY EXCRETION;

EID: 0037024519     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04422.x     Document Type: Conference Paper

References (21)

1. Pearse, A.G.E. 1980. The APUD concept and hormone production. Clin. Endocrinol. Metab. 17: 211-222.
2. Williams, E.D. & M. Sandler. 1963. The classification of carcinoid tumors. Lancet 1: 238-239.
3. Thorson, A., G. Björck, G. Björkman, et al. 1954. Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation with septal defects), peripheral vasomotor symptoms, bronchoconstriction and an unusual type of cyanosis, a clinical and pathological syndrome. Am. Heart J. 47: 795-817.
4. Norheim, I., K. Öberg, E. Theodorsson-Norheim, et al. 1987. Malignant carcinoid tumors: An analysis of 103 patients with regard to tumor localization, hormone production and survival. Ann. Surg. 206: 115-125.
5. 3]-octreotide: The Rotterdam experience with more than 1,000 patients. Eur. J. Nucl. Med. 20: 716-731.
6. 1]-Octreotide scintigraphy in patients with carcinoid tumors - The predictive value for somatostatin analogue treatment. Eur. J. Endocrinol. 131: 575-576.
7. Eriksson, B. & K. Öberg. 1993. An update of the medical treatment of malignant endocrine pancreatic tumors. Acta Oncol. 32: 203-208.
8. Öberg, K. & B. Eriksson. 1991. The role of interferons in the management of carcinoid tumors. Acta Oncol. 30: 519-522.
9. Andersson, T., B. Eriksson, P.G. Lindgren, et al. 1990. Effects of interferon on tumor tissue content in liver metastases during interferon treatment. Cancer Res. 50: 3413-3415.
10. Imam, H., B. Eriksson, A. Lukinius, et al. 1997. Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs. Acta Oncol. 36: 607-614.
11. Moertel, C.G., L.K. Kools, M.J. O'Connell, et al. 1991. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Cancer 68: 227-232.
12. Adams, S., R. Baum, T. Rink, et al. 1998. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur. J. Nucl. Med. 25: 79-83.
13. Örlefors, H., A. Sundin, A. Lilja, et al. 1998. Positron emission tomography (PET) with 5-hydroxytryptophan (5-HTP) in the diagnosis and treatment follow-up of carcinoid tumors. J. Clin. Oncol. 7: 2534-2541.
14. 11C]-5-hydroxy-L-tryptophan accumulation and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography. Nucl. Med. Biol. 27: 33-41.
15. 11C-labeled-5-hydroxytryptophan. Biogenic Amines 12: 477-485.
16. Ahlström, H., B. Eriksson, M. Bergström, et al. 1995. Pancreatic neuroendocrine tumors: Diagnosis with PET. Radiology 195: 333-337.
17. Kloos, R.T., M.D. Gross, I.R. Francis, et al. 1995. Incidentally discovered adrenal masses. Endocr. Rev. 16: 460-484.
18. Gröndahl, S., B. Eriksson, L. Hagenäs, et al. 1990. Steroid profile in urine: A useful tool in the diagnosis and follow up of adrenocortical carcinoma. Acta Endocrinol. 122: 656-663.
19. Weber, M.M., J. Lang, F. Abedinpour, et al. 1993. Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis. Clin. Invest. 71: 993-1038.
20. Bergström, M., T. Bonasera, L. Lu, et al. 1998. In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors. J. Nucl. Med. 39: 982-989.
21. 11C-metomidate. J. Nucl. Med. 41: 275-282.